Plasminogen-activator-producing Tumour
- 11 January 1969
- Vol. 1 (5636) , 88-91
- https://doi.org/10.1136/bmj.1.5636.88
Abstract
In a patient with giant-cell carcinoma of the lung a secondary tumour deposit in the arm was incised and bled for three weeks. Investigations showed the tumour to be rich in plasminogen activator. Haemostasis in the tumour was achieved with aminocaproic acid therapy. For a period the plasminogen-activator properties were retained in cell culture of the tumour.Keywords
This publication has 12 references indexed in Scilit:
- ORIGIN OF FIBRINOLYTIC ACTIVITY IN CULTURES OF HUMAN KIDNEY1967
- Quantitative Estimation of Split Products of Fibrinogen in Human Serum, Relation to Diagnosis and TreatmentBlood, 1966
- Plasma Fibrinolytic Activity in Renal DiseaseScottish Medical Journal, 1965
- Giant-cell carcinoma of the lung:A dedifferentiated adenocarcinomaCancer, 1965
- LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUESBritish Medical Bulletin, 1964
- A review of unusual systemic manifestations associated with carcinomaThe American Journal of Medicine, 1964
- Rotation-mediated histogenetic aggregation of dissociated cellsExperimental Cell Research, 1961
- Giant cell carcinoma of the lung. Report of 5 casesCancer, 1958
- ACTIVATION OF PLASMINOGENAnnals of the New York Academy of Sciences, 1957
- Prostatic fibrinolysinThe American Journal of Medicine, 1953